Navigation Links
United Biotech Launches New Oncology Division

India-based United Biotech is diversifying into the oncology segment starting with the launch of its new oncology division at an initial// investment of $3.4 million.

The company has established a state-of-the-art division for oncology at its facility in Baddi, Himachal Pradesh (India). This new division is set up in collaboration with Blausiegel, a Brazilian company, for its entire range of biotechnology products used specifically for the treatment of cancer. The company is also in talks with four other global pharma companies for strategic tie-ups for its oncology business.

With this launch, the company intends to manufacture and market molecules that are currently being exclusively marketed by multinationals. The company also intends to offer the products at a much lower price than that offered by the multinationals.

“To funnel our short term growth plan in the oncology segment we aim to tap the global oncology generics business opportunity worth $14–15 billion dollars in the next five years. While our long term growth plan in the oncology segment will come through new drug delivery systems (NDDS) being developed by our in-house scientists and supplementing its strength through alliances. United Biotech will follow multi-pronged strategies for its continuous growth across all therapeutic segments that it is currently in operation,” said Mr R K Dewan, Vice President Marketing, United Biotech.

Source: BioSpectrum
SRMB
'"/>




Page: 1

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
3. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
4. United Kingdom to perform its first Live Liver Transplant
5. Inhospitable Response Curtail Growth Of Specialty Hospitals: United States
6. United Kingdom: Farmers Cautioned To Plan Adequately For Bird-Flu
7. Bird-Flu Causes Alarm in United Kingdom.
8. 2010 AIDS Target May Misfire, Warns United Nations
9. AIDS Meet Ends Without Firm Commitments From Donors Dharam Shourie United Nations
10. United Nations draws flak Due to Lukewarm AIDS Prevention Measures
11. Chinese Poultry Smuggled into United States
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... Pa. (PRWEB) , ... December 08, 2016 , ... ... Medicine Southern Chester County, a Property owned by an affiliate of Seavest, has ... square foot Penn Medicine Southern Chester County ambulatory care center (ACC) was named ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... access for customers and employees that are both engaging and easy to use. ... Smart Technology, the software company revealed today its plans to roll out new ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... has been recognized for adherence to the highest standards of trauma, maternity, ... organizations, announced the center's president and CEO, Dr. Daniel Messina. , Among the ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016   Hudes Laser ... December featuring the multi-wavelength Astanza Trinity laser and ... specializes in laser tattoo removal, IPL hair removal, ... ultrasound therapy. Hudes Laser Aesthetica is setting high ... and promises to deliver effective, long-lasting ...
(Date:12/9/2016)... OSAKA, Japan , Dec. 9, 2016 ... ; President & Representative Director, CEO: Dr. ... with amyotrophic lateral sclerosis (ALS) given edaravone intravenously in ... functional loss as measured by the ALS Functional Rating ... th International Symposium on ALS/MND in ...
(Date:12/9/2016)... 9, 2016  Axovant Sciences Ltd. (NYSE: ... focused on the treatment of dementia, today announced ... Phase 2b trial evaluating treatment with intepirdine (RVT-101), ... donepezil plus placebo in people with mild-to-moderate Alzheimer,s ... intepirdine to treatment was associated with reduced progression ...
Breaking Medicine Technology: